<code id='F0AC6E5A8A'></code><style id='F0AC6E5A8A'></style>
    • <acronym id='F0AC6E5A8A'></acronym>
      <center id='F0AC6E5A8A'><center id='F0AC6E5A8A'><tfoot id='F0AC6E5A8A'></tfoot></center><abbr id='F0AC6E5A8A'><dir id='F0AC6E5A8A'><tfoot id='F0AC6E5A8A'></tfoot><noframes id='F0AC6E5A8A'>

    • <optgroup id='F0AC6E5A8A'><strike id='F0AC6E5A8A'><sup id='F0AC6E5A8A'></sup></strike><code id='F0AC6E5A8A'></code></optgroup>
        1. <b id='F0AC6E5A8A'><label id='F0AC6E5A8A'><select id='F0AC6E5A8A'><dt id='F0AC6E5A8A'><span id='F0AC6E5A8A'></span></dt></select></label></b><u id='F0AC6E5A8A'></u>
          <i id='F0AC6E5A8A'><strike id='F0AC6E5A8A'><tt id='F0AC6E5A8A'><pre id='F0AC6E5A8A'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:38
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more
          Congress extends some pandemic preparedness programs
          Congress extends some pandemic preparedness programs

          STEFANIREYNOLDS/AFPviaGettyImagesWASHINGTON—Congresstemporarilyextendedafewpandemic-preparednessprog

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          What American doctors can learn from their Israeli counterparts

          IsraelisgatherinTelAvivforthe34thconsecutiveweektoprotestagainstplansbyPrimeMinisterBenjaminNetanyah